Author

Tejaswini C. Cherukuri

Cincinnati Children's Hospital Medical Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Anil Goud JeggaiD· 1 shared Harshavardhana H. EdigaiD· 1 shared Jaswanth YellaiD· 1 shared Satish Kumar MadalaiD· 1 shared Sudhir K. GhandikotaiD· 1 shared Yunguan WangiD· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Anil Goud JeggaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pan-transcriptome-based Candidate Therapeutic Discovery for Idiopathic Pulmonary Fibrosis

Yunguan Wang, Jaswanth Yella, Sudhir K. Ghandikota, Tejaswini C. Cherukuri, Harshavardhana H. Ediga, Satish Kumar Madala, Anil Goud Jegga

This study identifies 77 potential therapeutics for IPF by analyzing gene expression and drug-perturbagen connectivity, including FDA-approved drugs and clinical trial compounds.

Therapeutic Advances in Respiratory Disease · Jan 1, 2020Peer-reviewedGenomics